Top U.S. Marijuana Stocks to Watch in February 2026
The U.S. cannabis sector continues to evolve as 2026 begins, creating both risk and opportunity for investors. After years of regulatory uncertainty, many operators are now focused on efficiency, balance sheet repair, and selective growth. Meanwhile, potential federal reform remains a major catalyst that could reshape valuations across the industry. As a result, investors are becoming more selective when building watchlists.
Rather than chasing hype, many traders now focus on companies with established footprints, improving cash flow trends, and strong market positioning. Additionally, multi-state operators with scalable infrastructure may benefit the most from future regulatory tailwinds. This includes potential changes to federal tax treatment and banking access.
However, the cannabis space remains volatile, so disciplined risk management is essential. Many stocks continue to trade well below prior highs, creating asymmetric setups for patient investors. At the same time, weaker operators may struggle if capital markets remain tight. Therefore, company selection matters more than ever.
February 2026 could be an important month for the sector. Earnings updates, regulatory headlines, and broader market sentiment may all influence price action. Because of this, investors often look for stocks that combine scale, brand strength, and improving financial discipline.
This article highlights three U.S. marijuana stocks worth watching closely this month. Each company operates at scale within the United States and maintains a meaningful dispensary presence. Additionally, each name reflects a different strategic approach within the cannabis ecosystem.
The companies covered include AYR Wellness, Cresco Labs, and Glass House Brands. Together, they offer a cross-section of the broader cannabis landscape. Investors should watch how these companies execute as the industry enters its next phase.
[Read More] Today’s Top Marijuana Stock Picks For Investors
Best U.S. Marijuana Stocks to Watch This February
- AYR Wellness Inc. (OTC: AYRWF)
- Cresco Labs Inc. (OTC: CRLBF)
- Glass House Brands Inc. (OTC: GLASF)
AYR Wellness Inc. (AYRWF)
AYR Wellness is a vertically integrated U.S. cannabis operator with a growing national footprint. The company operates cultivation, manufacturing, and retail assets across several regulated states. Its largest presence is in Florida, where it serves a sizable medical cannabis population. AYR also operates in states like Pennsylvania, Ohio, Nevada, and Massachusetts. This geographic diversification helps reduce reliance on a single market.
The company runs dozens of dispensaries under the AYR and The Dispensary banners. These stores focus on both accessibility and product consistency. Additionally, AYR manages a portfolio of in-house brands that span multiple product categories. This includes flower, vapes, concentrates, and edibles. The company emphasizes operational control across the entire supply chain. As a result, AYR can adjust production based on changing market demand.
AYR has spent recent years refining its footprint rather than expanding aggressively. This shift reflects broader industry trends toward efficiency and cost control. Moreover, management has emphasized disciplined growth over rapid expansion. This strategy may position the company better during uncertain market conditions.
From a financial perspective, AYR has faced pressure from debt and operating costs. Revenue has remained relatively stable, although profitability has lagged. Therefore, management initiated restructuring efforts to strengthen liquidity and reduce financial strain. These efforts include refinancing obligations and rationalizing certain assets.
While near-term earnings remain challenged, cost controls are improving gradually. Additionally, cash flow trends have become a key focus for investors. Any improvement in federal tax treatment could materially impact AYR’s margins. Consequently, the stock often reacts sharply to regulatory headlines. AYR remains a higher-risk name, yet it offers turnaround potential if execution improves.
[Read More] Best U.S. Marijuana Stocks to Follow as February 2026 Begins
Cresco Labs Inc. (CRLBF)
Cresco Labs is one of the most established multi-state operators in the U.S. cannabis industry. The company operates across cultivation, manufacturing, wholesale, and retail channels. Its flagship Sunnyside dispensary brand has a strong presence in several core markets. These include Illinois, Pennsylvania, Ohio, and Massachusetts. Importantly, Cresco maintains exposure to both medical and adult-use states.
Cresco’s scale sets it apart from many peers. The company distributes products to hundreds of third-party dispensaries nationwide. Additionally, its brand portfolio spans multiple consumer segments. This allows Cresco to compete effectively across different price points. Furthermore, the company prioritizes brand consistency and consumer trust.
Retail operations play a major role in Cresco’s strategy. Sunnyside locations focus on customer experience and repeat engagement. At the same time, Cresco’s wholesale business provides diversified revenue streams. This dual approach helps smooth revenue volatility across quarters.
Financially, Cresco generates some of the highest revenue totals among U.S. cannabis operators. Although net losses persist, margins remain relatively resilient. The company has focused on improving adjusted EBITDA and operating cash flow. Moreover, recent debt refinancing extended maturities and improved balance sheet flexibility.
Cresco continues to optimize underperforming assets while investing selectively in core markets. Investors often watch same-store sales trends closely. Any improvement there could signal stronger demand. Additionally, federal reform could unlock significant margin expansion. Cresco remains a bellwether stock for the U.S. cannabis sector overall.
[Read More] Best Ancillary Cannabis Stocks to Watch in February 2026
Glass House Brands Inc. (GLASF)
Glass House Brands is a vertically integrated cannabis company with a strong California focus. The company operates one of the largest greenhouse cultivation footprints in the United States. Its core operations span cultivation, manufacturing, wholesale, and retail. Glass House primarily serves California’s adult-use market, which remains the largest in the country.
The company’s cultivation scale is a defining feature. Large greenhouse facilities allow for cost-efficient production at scale. This provides a potential advantage during periods of price compression. Additionally, Glass House distributes products through both company-owned and third-party dispensaries. Its retail presence includes branded storefronts and delivery channels.
Glass House also owns several recognizable cannabis brands. These brands cover flower, pre-rolls, and infused products. Vertical integration allows tighter quality control and margin capture. As a result, management emphasizes operational efficiency and production optimization.
Financial performance has been uneven, reflecting broader California market challenges. Pricing pressure and regulatory costs have impacted margins. However, production volumes have increased as facilities ramp toward full utilization. The company has also taken steps to refinance debt and stabilize liquidity.
Looking ahead, Glass House’s scale could become more valuable if pricing stabilizes. Higher capacity utilization may drive revenue growth over time. Additionally, any improvement in California’s regulatory environment could support margins. Investors often view GLASF as a leveraged play on California market recovery. While risk remains elevated, the upside could be meaningful if conditions improve.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
